SCHEMBL19867043

SCHEMBL19867043

CC(O)C(NC(=O)N[C@@H](CC(=O)O)c1nc(-c2cnccn2)no1)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VSIR Q9H7M9 3/20 0.51
CD274 Q9NZQ7 3/20 0.51
BMP1 P13497 1/20 0.40
PDCD1LG2 Q9BQ51 1/20 0.35
CTSA P10619 1/20 0.35
PDCD1 Q15116 1/20 0.35
POLB P06746 1/20 0.34
LMNA P02545 1/20 0.34
TSHR P16473 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
NPC1 O15118 1/20 0.33
PKM P14618 1/20 0.33
RAB9A P51151 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
PDF Q9HBH1 1/20 0.33
HCAR2 Q8TDS4 1/20 0.33
EPHX2 P34913 1/20 0.32
KCNH2 Q12809 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ATM Q13315 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18077954 1.00 VSIR (0.51) VSIRCD274BMP1PDCD1LG2CTSA
SCHEMBL19867019 0.92 CD274 (0.61) VSIRCD274BMP1PDCD1LG2PDCD1
SCHEMBL18077966 0.92 CD274 (0.61) VSIRCD274BMP1PDCD1LG2PDCD1
SCHEMBL18077937 0.90 VSIR (0.45) VSIRCD274BMP1PDCD1LG2POLB
SCHEMBL19866982 0.90 VSIR (0.45) VSIRCD274BMP1PDCD1LG2POLB
SCHEMBL19866989 0.89 VSIR (0.45) VSIRCD274BMP1PDCD1LG2PDCD1
SCHEMBL18078012 0.89 VSIR (0.45) VSIRCD274BMP1PDCD1LG2PDCD1
SCHEMBL19981134 0.85 BMP1 (0.39) VSIRCD274BMP1CTSAPOLB
SCHEMBL18077944 0.79 VSIR (0.61) VSIRCD274BMP1PDCD1LG2PDCD1
SCHEMBL19867037 0.79 VSIR (0.61) VSIRCD274BMP1PDCD1LG2PDCD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180044329-A1 3-SUBSTITUTED-1,2,4-OXADIAZOLE AND THIADIAZOLE COMPOUNDS AS IMMUNOMODULATORS AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180044329-A1 3-SUBSTITUTED-1,2,4-OXADIAZOLE AND THIADIAZOLE COMPOUNDS AS IMMUNOMODULATORS PDCD1, CD274, PDCD1LG2 VSIR 2158/4885CD274 2/4885BMP1 2187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.